Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
/PRNewswire/ -- Occlutech Holding AG ("Occlutech"), one of the world´s leading providers of minimally invasive structural heart disease devices, announces the...
Source: prnewswire.com